Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.2% | −5.3% | −0.7% | +1.7% | +18.6% | — | — | — | — | +19.4% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$169 of every $1,000 in PBPH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLY.TOELI Lilly | Healthcare | 16.87% | $1,687.40 | 168K | $226.9M |
| 2 | JNJ.TOJohnson & Johnson | Healthcare | 9.55% | $954.67 | 480K | $128.4M |
| 3 | ABBVAbbvie | Healthcare | 7.43% | $742.54 | 352K | $99.8M |
| 4 | —Roche AG | — | 4.96% | $496.32 | 141K | $66.7M |
| 5 | MRKMerck | Healthcare | 4.86% | $486.43 | 492K | $65.4M |
| 6 | AZN.LAstrazeneca | Healthcare | 4.66% | $466.10 | 359K | $62.7M |
| 7 | AMGNAmgen | Healthcare | 4.28% | $428.32 | 132K | $57.6M |
| 8 | GILD.TOGilead Sciences | Healthcare | 4.18% | $418.13 | 338K | $56.2M |
| 9 | NOVN.SWNovartis Ag-reg | Healthcare | 4.07% | $407.27 | 363K | $54.8M |
| 10 | PFE.BAPfizer | Healthcare | 3.18% | $318.20 | 1.6M | $42.8M |
| 11 | VRTXVertex Pharmaceuticals | Healthcare | 2.66% | $265.75 | 69K | $35.7M |
| 12 | —Novo Nordisk A/s-b | — | 2.52% | $251.75 | 869K | $33.8M |
| 13 | BMYBristol-myers Squibb | Healthcare | 2.42% | $241.52 | 557K | $32.5M |
| 14 | SAN.PASanofi | Healthcare | 2.02% | $201.74 | 295K | $27.1M |
| 15 | REGNRegeneron Pharmaceuticals | Healthcare | 1.85% | $185.35 | 27K | $24.9M |
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 24, 2025 | Dec 26, 2025 | $0.0230 |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY.TO | ELI Lilly & | 16.87% |
| 2 | JNJ.TO | Johnson & Johnson | 9.55% |
| 3 | ABBV | Abbvie | 7.43% |
| 4 | MRK | Merck & | 4.86% |
| 5 | AZN.L | Astrazeneca | 4.66% |
| 6 | AMGN | Amgen | 4.28% |
| 7 | GILD.TO | Gilead Sciences | 4.18% |
| 8 | NOVN.SW | Novartis Ag-reg | 4.07% |
| 9 | PFE.BA | Pfizer | 3.18% |
| 10 | VRTX | Vertex Pharmaceuticals | 2.66% |